Lv32
270 积分 2025-01-08 加入
Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide‐resistant proliferative lupus nephritis
5天前
已完结
Rituximab use in pediatric systemic lupus erythematosus: Indications, efficacy and safety in an Indian cohort
5天前
已完结
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases
5天前
已完结
Efficacy and Safety of Rituximab in the Management of Pediatric Systemic Lupus Erythematosus: A Systematic Review
5天前
已完结
Rituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases
6天前
已完结
Anti-CD20 monoclonal antibodies in Systemic Lupus Erythematosus
6天前
已完结
Juvenile-onset systemic lupus erythematosus: Update on clinical presentation, pathophysiology and treatment options
6天前
已完结
Pathogenesis of autoimmune disease
6天前
已完结
Autologous CD19‐ targeting CAR T cells in refractory juvenile dermatomyositis
26天前
已完结
B-cell-directed therapies for autoimmune disease
1个月前
已完结
皖公网安备34019202002308
